Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Toronto
$27,000.00
Investigating the role of the aged bone marrow niche on SRSF2 P95H clonal hematopoiesis
EF 2025-26
Résumé
Clonal hematopoiesis (CH) is a pre-cancerous state that occurs when the DNA sequence of a blood stem cell changes in a way that gives it an abnormal advantage, allowing it to grow and replicate faster than its healthy counterparts. CH is associated with a 10-fold increased risk of developing various blood cancers, including acute myeloid leukemia. Notably, the chance of developing CH increases significantly with age. 20% of individuals by the age of 70 have detectable CH. Therefore, it is important to understand CH and its association with aging, which is essential to the development of early interception strategies to prevent malignant transformation in high-risk patients with CH.
Serine and Arginine-rich Splicing Factor 2 (SRSF2) is a protein in human body that is important for protein expression. A change in the DNA sequence of SRSF2 is one of the most common types of CH, and is linked to a particularly high risk of blood cancer development and progression. Interestingly, it is found much more frequently in the elderly, suggesting its unique advantage within the aging human system. The bone marrow microenvironment within the bone, which supports the production of various blood cells, can be severely affected by aging, characterized by an increased rate of inflammation and a loss of regeneration capability. Additionally, changes of the bone marrow niche are often observed in late stage leukemia. Despite these observations, the impact of the aged bone marrow niche in SRSF2-associated CH leading to leukemia initiation has yet to be functionally or mechanistically described. Therefore, my proposed research project aims to investigate whether and how the aged bone marrow can contribute to SRSF2-associated CH.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
573333
Name
Wang Keheng
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of the aged bone marrow niche on SRSF2 P95H clonal hematopoiesis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Aging; Bone Marrow Niche; Cancer Prevention; Clonal Hematopoiesis; Genetic Mutation; Hematopoietic Stem Cell; Leukemia; Mesenchymal Stromal Cell; Rna-Binding Protein; Splicing Factor
Abstract
Clonal hematopoiesis (CH) is a pre-cancerous state that occurs when the DNA sequence of a blood stem cell changes in a way that gives it an abnormal advantage, allowing it to grow and replicate faster than its healthy counterparts. CH is associated with a 10-fold increased risk of developing various blood cancers, including acute myeloid leukemia. Notably, the chance of developing CH increases significantly with age. 20% of individuals by the age of 70 have detectable CH. Therefore, it is important to understand CH and its association with aging, which is essential to the development of early interception strategies to prevent malignant transformation in high-risk patients with CH.
Serine and Arginine-rich Splicing Factor 2 (SRSF2) is a protein in human body that is important for protein expression. A change in the DNA sequence of SRSF2 is one of the most common types of CH, and is linked to a particularly high risk of blood cancer development and progression. Interestingly, it is found much more frequently in the elderly, suggesting its unique advantage within the aging human system. The bone marrow microenvironment within the bone, which supports the production of various blood cells, can be severely affected by aging, characterized by an increased rate of inflammation and a loss of regeneration capability. Additionally, changes of the bone marrow niche are often observed in late stage leukemia. Despite these observations, the impact of the aged bone marrow niche in SRSF2-associated CH leading to leukemia initiation has yet to be functionally or mechanistically described. Therefore, my proposed research project aims to investigate whether and how the aged bone marrow can contribute to SRSF2-associated CH.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wang, Keheng
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~